Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
89.60
+1.03 (1.16%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Merit Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,579 | 1,516 | 1,357 | 1,257 | 1,151 | 1,075 | |
Revenue Growth | 10.19% | 11.75% | 7.89% | 9.24% | 7.09% | 11.50% |
Cost of Revenue | 797.09 | 777.64 | 713.18 | 673.49 | 631.88 | 589.42 |
Gross Profit | 781.73 | 738.27 | 643.33 | 583.87 | 519.1 | 485.33 |
Selling, General & Admin | 468.67 | 447.01 | 387.83 | 366.08 | 335.33 | 329.69 |
Research & Development | 98.51 | 97.35 | 87.47 | 82.73 | 75.51 | 71.25 |
Operating Expenses | 567.18 | 544.37 | 475.3 | 448.8 | 410.84 | 400.94 |
Operating Income | 214.55 | 193.9 | 168.04 | 135.07 | 108.26 | 84.4 |
Interest Expense | -31.76 | -26.46 | -31.22 | -15.51 | -6.34 | -5.26 |
Interest & Investment Income | 15.17 | 15.07 | 26.23 | 2.46 | 0.44 | 0.77 |
Currency Exchange Gain (Loss) | -4.73 | -0.1 | 1.96 | 2 | 1.42 | -1.6 |
Other Non Operating Income (Expenses) | 1.85 | -2.29 | -2.67 | -0.8 | -0.45 | -0.91 |
EBT Excluding Unusual Items | 195.09 | 180.12 | 162.34 | 123.21 | 103.33 | 77.4 |
Merger & Restructuring Charges | -13.4 | -8.2 | -11.9 | -7.6 | -7.2 | -2.7 |
Gain (Loss) on Sale of Investments | - | - | - | -0.27 | -0.5 | - |
Gain (Loss) on Sale of Assets | 12.56 | - | - | - | - | - |
Asset Writedown | - | - | - | - | -1.72 | -1.58 |
Legal Settlements | - | - | - | - | - | -10.04 |
Other Unusual Items | 0.22 | -0.98 | -0.44 | -1.7 | -4.61 | -9.16 |
Pretax Income | 194.46 | 170.94 | 149.99 | 112.09 | 82.63 | 53.92 |
Income Tax Expense | 48.9 | 42.45 | 29.64 | 17.68 | 8.11 | 5.46 |
Net Income | 145.56 | 128.49 | 120.36 | 94.41 | 74.52 | 48.45 |
Net Income to Common | 145.56 | 128.49 | 120.36 | 94.41 | 74.52 | 48.45 |
Net Income Growth | 22.20% | 6.76% | 27.48% | 26.70% | 53.79% | - |
Shares Outstanding (Basic) | 59 | 59 | 58 | 58 | 57 | 56 |
Shares Outstanding (Diluted) | 60 | 60 | 59 | 58 | 58 | 57 |
Shares Change | -0.86% | 1.85% | 1.73% | 1.19% | 0.54% | 3.47% |
EPS (Basic) | 2.45 | 2.17 | 2.07 | 1.64 | 1.31 | 0.86 |
EPS (Diluted) | 2.43 | 2.13 | 2.03 | 1.62 | 1.29 | 0.84 |
EPS Growth | 23.23% | 4.93% | 25.31% | 25.58% | 53.57% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 203.21 | 215.66 | 185.66 | 110.86 | 69.26 | 119.29 |
Free Cash Flow Per Share | 3.39 | 3.57 | 3.13 | 1.90 | 1.20 | 2.08 |
Gross Margin | 49.51% | 48.70% | 47.42% | 46.44% | 45.10% | 45.16% |
Operating Margin | 13.59% | 12.79% | 12.39% | 10.74% | 9.41% | 7.85% |
Profit Margin | 9.22% | 8.48% | 8.87% | 7.51% | 6.47% | 4.51% |
Free Cash Flow Margin | 12.87% | 14.23% | 13.69% | 8.82% | 6.02% | 11.10% |
EBITDA | 338.94 | 317.07 | 270.75 | 225.05 | 190.07 | 168.46 |
EBITDA Margin | 21.47% | 20.92% | 19.96% | 17.90% | 16.51% | 15.68% |
D&A For EBITDA | 124.39 | 123.17 | 102.71 | 89.99 | 81.8 | 84.07 |
EBIT | 214.55 | 193.9 | 168.04 | 135.07 | 108.26 | 84.4 |
EBIT Margin | 13.59% | 12.79% | 12.39% | 10.74% | 9.41% | 7.85% |
Effective Tax Rate | 25.15% | 24.83% | 19.76% | 15.77% | 9.82% | 10.13% |